ADA, Washington 2006

Five poster presentations and one oral presentation of PROactive data will be given at the American Diabetes Association Annual Scientific Sessions that will be held 9-13 June 2006 in Washington, DC.

• Wilcox R. Effects of Pioglitazone on Major Adverse Cardiovascular Events (MACE) and Myocardial Infarction: Results from PROactive (Oral Presentation Number: 317-OR)
  
  
• Heine R et al. Long-Term Pioglitazone Treatment Improves Markers of Liver Function: Results from PROactive (Poster Presentation Number: 484-P)
  
  
• Scheen A & Charbonnel B. Reduced Insulin Requirements and Improved Glycaemic Control with Pioglitazone in Insulin-Treated Patients with > Type 2 Diabetes:  Results from PROactive (Poster Presentation Number: 561-P)
  
  
• Charbonnel B & Scheen A. Pioglitazone in Triple Oral Therapy: Long-Term Glycaemic Results from PROactive (Poster Presentation Number: 448-P)
  
  
• Massi-Benedetti M et al. Pioglitazone Delays the Need for Permanent Insulin Use: Results from PROactive (Poster Presentation Number: 523-P)
  
  
• Wilcox R et al. Effect of Pioglitazone in Stroke Prevention in Type 2 Diabetes: A Prespecified Subgroup Analysis of PROactive (Poster Presentation Number: 579-P)